Therefore, novel tau-related models are needed for a more accurate study of AD and other tauopathies, including those bearing humanized (non-mutated) Mapt genes and KI animals, probably in combination with other transgenes so as to better mimic the spatiotemporal pathological phenomena of this neurodegenerative disease. The gene discussed is MAPT; the disease is Alzheimer disease.